Hydroxylamine derivatives as potential inhibitors of nucleic acid synthesis.
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism; D004273:DNA, Neoplasm / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D003864:Depression, Chemical; D004926:Escherichia coli / Q000187:drug effects; D006877:Hydroxamic Acids / Q000138:chemical synthesis / Q000494:pharmacology; D006898:Hydroxylamines / Q000138:chemical synthesis* / Q000494:pharmacology / Q000633:toxicity; D008706:Methemoglobin / Q000096:biosynthesis; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D009696:Nucleic Acids / Q000096:biosynthesis*; D012334:RNA, Neoplasm / Q000037:antagonists & inhibitors / Q000096:biosynthesis
D004273:DNA, Neoplasm; D006877:Hydroxamic Acids; D006898:Hydroxylamines; D009363:Neoplasm Proteins; D009696:Nucleic Acids; D012334:RNA, Neoplasm; D008706:Methemoglobin